Effects of the MYC oncogene antagonist, MAD, on proliferation, cell cycling and the malignant phenotype of human brain tumour cells

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Nature Medicine

• Publication date

  1995-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/nm0795-638PMID 7585143
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Stabilization of c-myc protein in human glioma cells

  2004cited by this paper
• Mad-Max transcriptional repression is mediated by ternary complex formation with mammalian homologs of yeast repressor Sin3.

  1995cited by this paper
• In vivo molecular therapy with p53 adenovirus for microscopic residual head and neck squamous carcinoma.

  1995cited by this paper
• Oncogenes and cell death.

  1994cited by this paper
• Repression of cyclin D1: a novel function of MYC.

  1994cited by this paper
• Myc-Max-Mad: a transcription factor network controlling cell cycle progression, differentiation and death.

  1994cited by this paper
• Expression of mad, mxi1, max and c-myc during induced differentiation of hematopoietic cells: opposite regulation of mad and c-myc.

  1994cited by this paper
• Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age.

  1994cited by this paper
• Suppression of Myc, but not E1a, transformation activity by Max-associated proteins, Mad and Mxi1.

  1994cited by this paper
• Mapping of two genes encoding members of a distinct subfamily of MAX interacting proteins: MAD to human chromosome 2 and mouse chromosome 6, and MXI1 to human chromosome 10 and mouse chromosome 19.

  1994cited by this paper
• Dysfunction of the Myc-induced apoptosis mechanism accompanies c-myc activation in the tumorigenic L929 cell line.

  1994cited by this paper
• Mxi1, a protein that specifically interacts with Max to bind Myc-Max recognition sites.

  1993cited by this paper
• Selective inhibition of ras-dependent transformation by a farnesyltransferase inhibitor.

  1993cited by this paper
• The role of c-myc in cell growth.

  1993cited by this paper
• Mad: a heterodimeric partner for Max that antagonizes Myc transcriptional activity.

  1993cited by this paper
• Effects of c-myc expression on proliferation, quiescence, and the G0 to G1 transition in nontransformed cells.

  1993cited by this paper
• A switch from Myc:Max to Mad:Max heterocomplexes accompanies monocyte/macrophage differentiation.

  1993cited by this paper
• Adenovirus-mediated transfer of the muscle glycogen phosphorylase gene into hepatocytes confers altered regulation of glycogen metabolism.

  1992cited by this paper
• Myc and Max associate in vivo.

  1992cited by this paper
• myc family oncogenes in the development of normal and neoplastic cells.

  1991cited by this paper
• Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc.

  1991cited by this paper
• Association of Myn, the murine homolog of max, with c-Myc stimulates methylation-sensitive DNA binding and ras cotransformation.

  1991cited by this paper
• Manipulation of adenovirus vectors.

  1991cited by this paper
• Sequence-specific DNA binding by the c-Myc protein.

  1990cited by this paper
• Role of c-myc in the transformation of REF52 cells by viral and cellular oncogenes.

  1987cited by this paper
• A c-myc antisense oligodeoxynucleotide inhibits entry into S phase but not progress from G0 to G1

  1987cited by this paper
• The human myc gene family.

  1986cited by this paper
• The regulation and expression of c-myc in normal and malignant cells.

  1986cited by this paper
• Differential responsiveness of myc- and ras-transfected cells to growth factors: selective stimulation of myc-transfected cells by epidermal growth factor

  1986cited by this paper
• Antigen-dependent proliferation of cloned continuous lines of H-2-restricted influenza virus-specific cytotoxic T lymphocytes.

  1981cited by this paper

• MNX1-AS1 promotes phase separation of IGF2BP1 to drive c-Myc-mediated cell cycle progression and proliferation in lung cancer.

  2022cites this paper
• MXD/MIZ1 transcription regulatory complexes activate the expression of MYC‐repressed genes

  2021cites this paper
• Lnc-HZ01 with m6A RNA methylation inhibits human trophoblast cell proliferation and induces miscarriage by up-regulating BPDE-activated lnc-HZ01/MXD1 positive feedback loop.

  2021cites this paper
• MXD/MIZ1 complexes activate transcription of MYC-repressed genes

  2019cites this paper
• Inhibiting Myc and the Myc dependent inflammatory response as cancer therapies.

  2017cites this paper
• Functional interactions among members of the MAX and MLX transcriptional network during oncogenesis.

  2015cites this paper
• An overview of MYC and its interactome.

  2014cites this paper
• MYC and MNT in transcriptional regulation and chromatin dynamics

  2014cites this paper
• Oct-2 Transcription Factor Binding Activity and Expression Up-Regulation in Rat Cerebral Ischaemia is Associated with a Diminution of Neuronal Damage In Vitro

  2013cites this paper
• Rapid Publication Tumor Suppression and Inhibition of Aneuploid Cell Accumulation in Human Brain Tumor Cells by Ectopic Overexpression of the Cyclin-dependent Kinase Inhibitor p 27 KIP 1

  2013cites this paper
• Myc proteins in brain tumor development and maintenance

  2012cites this paper
• Transcriptional Repression of Mad-Max Complex by Human Umbilical Cord Blood Stem Cells Downregulates Extracellular Signal-Regulated Kinase in Glioblastoma

  2012cites this paper
• Assessment of therapeutic targets in experimental models of Myc-induced lymphoma

  2011cites this paper
• Pathway identification combining metabolic flux and functional genomics analyses: acetate and propionate activation by Corynebacterium glutamicum.

  2009cites this paper
• Differential gene expression of bone marrow-derived CD34+ cells is associated with survival of patients suffering from myelodysplastic syndrome

  2009cites this paper
• Oesophageal adenocarcinoma is associated with a deregulation in the MYC/MAX/MAD network

  2008cites this paper
• Modelling Myc inhibition as a cancer therapy

  2008cites this paper
• c-MYC amplification and expression in astrocytic tumors

  2008cites this paper
• Regulation of the MAD1 promoter by G-CSF

  2008cites this paper
• c-Myc and ChREBP regulate glucose-mediated expression of the L-type pyruvate kinase gene in INS-1-derived 832/13 cells.

  2007cites this paper
• Expression and mutation analysis of genes that encode the Myc antagonists Mad1, Mxi1 and Rox in acute leukaemia

  2007cites this paper
• The Mad side of the Max network: antagonizing the function of Myc and more.

  2006cites this paper
• Targeting of the Myc pathway as a novel approach for cancer therapy

  2006cites this paper
• The Loss of PIN1 Deregulates Cyclin E and Sensitizes Mouse Embryo Fibroblasts to Genomic Instability*

  2006cites this paper
• Targeting of the Myc pathway as a novel approach for cancer therapy

  2006cites this paper
• Roles of Myc and Mad in cell cycle and apoptosis

  2006cites this paper
• MXI 1 , a Putative Tumor Suppressor Gene , Suppresses Growth of Human Glioblastoma Cells 1

  2006cites this paper
• The Transcriptional Repressor dMnt Is a Regulator of Growth in Drosophila melanogaster

  2005cites this paper
• Transforming Growth Factor-α Inhibits the Intrinsic Pathway of c-Myc-Induced Apoptosis through Activation of Nuclear Factor-κB in Murine Hepatocellular Carcinomas

  2005cites this paper
• Genomic binding and transcriptional regulation by the Drosophila Myc and Mnt transcription factors.

  2005cites this paper
• Transforming growth factor-alpha inhibits the intrinsic pathway of c-Myc-induced apoptosis through activation of nuclear factor-kappaB in murine hepatocellular carcinomas.

  2005cites this paper
• Control of growth and differentiation of human neuronal and hematopoietic tumour cells via Myc/Max/Mad-network proteins

  2005cites this paper
• Stress Signaling and Myc Downregulation: Implications for Cancer

  2004cites this paper
• Mad 1 inhibits cell growth and proliferation but does not promote differentiation or overall survival in human U-937 monoblasts.

  2004cites this paper
• c-Myc as a therapeutic target in cancer

  2004cites this paper
• Pharmacological inactivation of MYC for the treatment of cancer.

  2003cites this paper
• hMad4, c‐Myc endogenous inhibitor, induces a replicative senescence‐like state when overexpressed in human fibroblasts

  2003cites this paper
• Down-regulation of Myc as a Potential Target for Growth Arrest Induced by Human Polynucleotide Phosphorylase (hPNPaseold-35) in Human Melanoma Cells*

  2003cites this paper
• Increased resistance of tumor cells to hyperthermia mediated by integrin-linked kinase.

  2003cites this paper
• Low molecular weight inhibitors of Myc–Max interaction and function

  2003cites this paper
• Mad4 is regulated by a transcriptional repressor complex that contains Miz-1 and c-Myc.

  2003cites this paper
• The proto-oncogene c-myc in hematopoietic development and leukemogenesis

  2002cites this paper
• Repression of in vivo growth of Myc/Ras transformed tumor cells by Mad1

  2002cites this paper
• MAD1 and p27KIP1 Cooperate To Promote Terminal Differentiation of Granulocytes and To Inhibit Myc Expression and Cyclin E-CDK2 Activity

  2002cites this paper
• Mxi1 inhibits the proliferation of U87 glioma cells through down-regulation of cyclin B1 gene expression

  2002cites this paper
• Effect of the transcriptional repressor Mad1 on proliferation of human melanoma cells

  2002influential citation
• Expression of Mad1 in T cells leads to reduced thymic cellularity and impaired mitogen-induced proliferation

  2001cites this paper
• Regulation and function of the Mad/Max/Myc network during neuronal and hematopoietic differentiation.

  2001cites this paper
• Molecular mechanisms of corepressor function.

  2001cites this paper
• TGF-β1 Regulates the Expression of Multiple Max-Interacting Transcription Factors in Balb/MK Cells: Implications for Understanding the Mechanism of Action of TGF-β1

  2001cites this paper
• Retinoic acid–induced expression of autotaxin in N‐myc–amplified neuroblastoma cells

  2001cites this paper
• TGF-beta1 regulates the expression of multiple max-interacting transcription factors in Balb/MK cells: implications for understanding the mechanism of action of TGF-beta1.

  2001cites this paper
• Antisense-mediated depletion of p300 in human cells leads to premature G1 exit and up-regulation of c-MYC

  2001cites this paper
• S-phase-specific expression of the Mad3 gene in proliferating and differentiating cells.

  2001cites this paper
• Targeted Deletion of the S-Phase-Specific Myc Antagonist Mad3 Sensitizes Neuronal and Lymphoid Cells to Radiation-Induced Apoptosis

  2001cites this paper
• Mxi1, a Myc antagonist, suppresses proliferation of DU145 human prostate cells

  2001cites this paper
• AV.TK-mediated killing of subcutaneous tumors in situ results in effective immunization against established secondary intracranial tumor deposits

  2001cites this paper
• Inhibition of cell growth and apoptosis by inducible expression of the transcriptional repressor Mad1.

  2000cites this paper
• Mad1 Function Is Regulated through Elements within the Carboxy Terminus

  2000cites this paper
• Hepatocyte transplantation improves survival in mice with liver toxicity induced by hepatic overexpression of Mad1 transcription factor.

  2000cites this paper
• The Myc/Max/Mad network and the transcriptional control of cell behavior.

  2000cites this paper
• Inhibition of Proliferation and Apoptosis by the Transcriptional Repressor Mad1

  2000cites this paper
• Review: chromatin structural features and targets that regulate transcription.

  2000cites this paper
• Analysis of Myc/Max/Mad network members in adipogenesis: Inhibition of the proliferative burst and differentiation by ectopically expressed Mad1

  2000cites this paper
• Overexpression of Mad transcription factor inhibits proliferation of cultured human hepatocellular carcinoma cells along with tumor formation in immunodeficient animals

  2000cites this paper
• Gene transfer into brain parenchyma elicits antitumor effects.

  2000cites this paper
• Mad1 expression in the absence of differentiation: Effect of cAMP on the B‐lymphoid cell line Reh

  1999cites this paper
• The basic region/helix – loop – helix/leucine zipper domain of Myc proto-oncoproteins: Function and regulation

  1999cites this paper
• Mxi1 Is a Repressor of the c-myc Promoter and Reverses Activation by USF*

  1999cites this paper
• Posttranslational regulation of Myc function in response to phorbol ester/interferon-gamma-induced differentiation of v-Myc-transformed U-937 monoblasts.

  1999cites this paper
• Two MAD tails: what the recent knockouts of Mad1 and Mxi1 tell us about the MYC/MAX/MAD network.

  1999cites this paper
• Gamma interferon induces expression of Mad1 gene in macrophage, which inhibits colony‐stimulating factor‐1–dependent mitogenesis

  1999cites this paper
• New molecular strategies to cure brain tumors.

  1999cites this paper
• mad-overexpression down regulates the malignant growth and p53 mediated apoptosis in human hepatocellular carcinoma BEL-7404 cells

  1999cites this paper
• Dwarfism and dysregulated proliferation in mice overexpressing the MYC antagonist MAD1.

  1999cites this paper
• Mlx, a Novel Max-like BHLHZip Protein That Interacts with the Max Network of Transcription Factors*

  1999cites this paper
• Functional Analysis of the SIN3-Histone Deacetylase RPD3-RbAp48-Histone H4 Connection in the XenopusOocyte

  1999influential citation
• Hormone action and chromatin remodelling.

  1998cites this paper
• The proto-oncogene c-myc and apoptosis

  1998cites this paper
• Sequential expression of the MAD family of transcriptional repressors during differentiation and development

  1998cites this paper
• Key effectors of signal transduction and G1 progression.

  1998cites this paper
• Molecular Analysis of a Myc Antagonist, ROX/Mnt, at 17p13.3 in Human Lung Cancers

  1998cites this paper
• Targeted disruption of the MYC antagonist MAD1 inhibits cell cycle exit during granulocyte differentiation

  1998influential citation
• DNA-Dependent Protein Kinase Phosphorylation of I k B a and I k B b Regulates NFk B DNA Binding Properties

  1998cites this paper
• Identification and Characterization of Specific DNA-binding Complexes Containing Members of the Myc/Max/Mad Network of Transcriptional Regulators*

  1998cites this paper
• DNA-dependent protein kinase phosphorylation of IkappaB alpha and IkappaB beta regulates NF-kappaB DNA binding properties.

  1998cites this paper
• Review¶Hormone action and chromatin remodelling

  1998cites this paper
• Increased expression of the LAZ3 (BCL6) proto-oncogene accompanies murine skeletal myogenesis.

  1998cites this paper
• The Mad protein family links transcriptional repression to cell differentiation.

  1998cites this paper
• A glial-specific, repressible, adenovirus vector for brain tumor gene therapy.

  1998cites this paper
• Repression by the Mad(Mxi1)‐Sin3 complex

  1998cites this paper
• DNA-Dependent Protein Kinase Phosphorylation of IκBα and IκBβ Regulates NF-κB DNA Binding Properties

  1998cites this paper
• Rox, a novel bHLHZip protein expressed in quiescent cells that heterodimerizes with Max, binds a non‐canonical E box and acts as a transcriptional repressor

  1997cites this paper
• Histone deacetylases associated with the mSin3 corepressor mediate mad transcriptional repression.

  1997cites this paper
• Regulated expression and function of the c-Myc antagonist, Mad1, during a molecular switch from proliferation to differentiation.

  1997cites this paper
• Cell growth inhibition by the Mad/Max complex through recruitment of histone deacetylase activity.

  1997cites this paper
• Differential effects of nuclear receptor corepressor (N-CoR) expression levels on retinoic acid receptor-mediated repression support the existence of dynamically regulated corepressor complexes.

  1997cites this paper
• Tumor suppressor genes and human cancer.

  1997cites this paper
• Isolation and characterization of a novel gene from human glioblastoma multiforme tumor tissue

  1997cites this paper
• Repression of c-Myc responsive genes in cycling cells causes G1 arrest through reduction of cyclin E/CDK2 kinase activity

  1997cites this paper